KaloBios Pharma (KBIO) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts KBIO Hot Sheet
Join SI Premium – FREE
KaloBios Pharma (NASDAQ: KBIO) reported Q2 EPS of ($1.46), $0.22 better than the analyst estimate of ($1.68).
For earnings history and earnings-related data on KaloBios Pharma (KBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- Evercore ISI Adds Dell (DELL) to Tactical Outperform List
- Baird Starts Jersey Mike's Subs (JMKE) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
